Global Enzymatic Debridement Market By Type (Collagenase Product, and Papain Product), By Application (Hospitals, and Clinics), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2031

Market.us announces the publication of its most recently generated research report titled, “Global Enzymatic Debridement Market by product type (Collagenase, Papain, Other), By end-user (Hospitals, Clinics, Others) and by Region – Global Forecast to 2031.”, Which offers a holistic view of the global Enzymatic Debridement market through systematic segmentation that covers every aspect of the target market.

The global Enzymatic Debridement market is projected to be US$ 303.9 Mn in 2018 to reach US$ 687.7 Mn by 2028 at a CAGR of 8.5%.

The process by which the dead tissue from a wound is removed is called Debridement. When the chemical enzymes are used to treat dead tissue, it is referred to as enzymatic Debridement. The chemicals used for enzymatic debridements like bromelain, streptokinase, papain, validate and collagenase are obtained from plants and Micro-organism. This method is more set at aiming toward dead tissue compared to when body cells do the same, according to Wound Care Practices. The replacement of dead tissue is required for wound healing and healthy tissue formation. If this process of removal of tissue is not done in time, this might lead to infections and subsequent problems. Enzymatic debridement is much speedier than autolytic debridement. The process is simple to perform, and it’s very functional. Enzymatic debridement restricts bacterial overgrowth and other diseases that might cause sepsis, pain and further amputation.

Global Enzymatic Debridement Market Revenue (US$ Mn), 2018–2028 

Increasing awareness among patients about enzymatic debridement in the treatment of wound care and technological advancement and government initiatives for strengthening the overall healthcare infrastructure is expected to boost the enzymatic debridement market.

Different factors like increasing burn injuries, diabetic foot ulcers and the growing geriatric population are expected to fuel the growth of the target market.

However, the high prices of advanced wound care products are expected to hinder the growth of the target market.

The global Enzymatic Debridement market is segmented on the basis of product type, end-user and region. On the basis of product type, the market is segmented into collagenase products, papain products and other product types. The collagenase product accounts for the majority share in the global Enzymatic Debridement market, while the papain product is expected to register a significant growth rate over the forecast period. On the basis of end-users, the market is segmented into hospitals, clinics and other users. The hospitals account for a majority share in the global Enzymatic Debridement market, while the share of clinics follows it.

Global Enzymatic Debridement Market by End-user, 2018

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, South America and Middle East Africa. North America accounts for the majority share in the global Enzymatic Debridement market due to technological advancement and government initiatives for strengthening the overall healthcare infrastructure, followed by Europe. Emerging economies such as Asia-Pacific; China and India are expected to register the highest growth rate over the forecast period. South America and the Middle East and Africa are expected to register stable growth over the forecast period. North America region is the largest supplier of enzymatic debridement; Europe is the second-largest supplier of enzymatic debridement. North America and Europe are the largest consumption places.

The research report on the global enzymatic debridement market includes profiles of some of the major companies such as Smith and Nephew Plc., Virchow Biotech Private limited, MediWound Ltd., WeiBang Biopharm and Stratus Pharmaceuticals Inc.

Key Market Segments

Type

• Collagenase Product
• Papain Product

Application

• Hospitals
• Clinics

Key Market Players included in the report:

• Smith and Nephew Plc.
• Virchow Biotech Private limited
• MediWound Ltd.
• WeiBang Biopharm and Stratus Pharmaceuticals Inc

For the Enzymatic Debridement Market research study, the following years have been considered to estimate the market size: